JANE STREET GROUP, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 43 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2023$17,860
+12.0%
15,946
+12.0%
0.00%
Q4 2022$15,940
-91.9%
14,232
-83.5%
0.00%
Q1 2022$197,000
+245.6%
86,216
+314.7%
0.00%
Q4 2021$57,000
-61.7%
20,792
-16.2%
0.00%
Q3 2021$149,000
+43.3%
24,800
-55.2%
0.00%
Q2 2020$104,000
+48.6%
55,348
+33.8%
0.00%
Q1 2020$70,000
-28.6%
41,366
-58.9%
0.00%
Q2 2019$98,000100,5340.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,917,622$7,365,0000.21%
GSA CAPITAL PARTNERS LLP 54,092$102,0000.06%
Carmignac Gestion 1,937,608$3,643,0000.05%
OXFORD FINANCIAL GROUP, LTD. LLC 91,824$173,0000.03%
SIGNATUREFD, LLC 121,351$228,0000.01%
Tekla Capital Management LLC 165,330$311,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 184,000$346,0000.01%
GROUP ONE TRADING, L.P. 567,903$1,068,0000.01%
Integrated Advisors Network LLC 15,700$30,0000.00%
WEDBUSH SECURITIES INC 22,900$43,0000.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders